The coronavirus pandemic has highlighted a major flaw in the delivery of healthcare in the United States. Extensive federal rules and regulations are preventing providers from offering high quality care to their patients in a timely manner. The latest example of this issue was recently alleviated in the process of the development of new medical innovations. Despite […]
Back in September, President Donald Trump signed an Executive Order that instructed the Department of Health and Human Services (HHS) to design a “payment model” that would see Medicare Part B beneficiaries and the federal government pay “no more than the most-favored-nation price” for medication. Last week, the HHS announced it will test a Most […]
Thirty-one nonprofit organizations sent a letter to Congress calling on it to oppose legislative attempts to meddle with the current Medicare plan. A proposal called the Medicare Crisis Program Act seeks to expand eligibility and threatens the financial stability of Medicare by depleting the Hospital Insurance Trust Fund. The bill also opens the door to […]
Today, ACI, along with 75 organizations and activists, sent a letter to Congress opposing Medicare-for-All legislation that includes provisions for the government to set prescription prices. The letter is available online.
Senator and presidential-hopeful Elizabeth Warren (D-Ma) has made headlines in recent weeks by releasing the details of how she would fund her vision of Medicare-for-All. But far from the headlines, and hidden deep in her 9,000 word blueprint, lies her plan to put a stop to American medical innovation. By strong-arming innovators and removing all […]
Today, ACI joined twenty-two other nonprofits in support of legislation that would reduce the cost of medications by providing Medicare patients access to lower-cost generic drugs and biosimilars. The letter is available online.
Today, ACI released a coalition letter to Congress in opposition to creating an inflationary rebate penalty in Medicare Part D. You can download and print the letter here.
Cell and gene therapies have the potential to save lives and can offset significant direct and indirect costs to our healthcare system, thus saving taxpayers money in the long run, according to this broad coalition letter.
What if there was a way to simultaneously reduce the stunning levels of health care fraud in the United States while also combating the opioid crisis ravaging our communities? Well, there is. To read this op-ed, please visit the Morning Consult.
Replacing the current Medicare card with a high-tech “smart card” could help prevent billions of dollars in fraud while reducing medical errors and saving lives. To Read this op-ed, visit Real Clear Health.